Avammune Therapeutics - Total Funding, Funding Over Time, Funding By Rounds and More
Founded in 2020, Avammune Therapeutics operates in Health Tech industry. Initially focused on developing cutting-edge therapies for immune-related disorders, the company has evolved to offer personali...
Funding stage:
Series A
Last funding:
11/05/2025
Total funding:
$12.00 Mn+
Investors
Employee count:
16
Last 90d
16
Last 90d
Web traffic:
558
558
Last 30d
Last 30d
Avammune Therapeutics: Funding Highlights
Funding highlights of Avammune Therapeutics and a snapshot of its key metrics.
Total Funding$12.00 Mn+
Current StageGrowth Stage
Total Round(s)3
Funding Rounds
FAQs on Funding of Avammune Therapeutics
Health Tech Funded Avammune Therapeutics has raised a total funding of $12.00 million dollars as of 12 May 2025 across 3 rounds. Find the details around funding rounds, participating investors, and other insights of Avammune Therapeutics here...
Avammune Therapeutics has raised a total of $12.00 million dollars across 3 funding rounds and the last round was raised on 12 May 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links